The Liver Meeting 2026
Talk TLM Theater track
FGF21 analogs in focus: From pathways to clinical evidence in MASH
Sun, Nov 8, 2026 · 12:45–1:30 PM MST Convention Center: TLM Theater 3, Hall F, Colorado Convention Center
About this session
During this interactive session, Drs Arun Sanyal and Kris Kowdley will be highlighting current gaps in the management of steatotic liver disease, reviewing the mechanisms of FGF21 analogs in MASH and discussing the clinical evidence for FGF21 analogs in MASH management. Industry Supporter: Novo Nordisk
